Katie told her father she was going to get the Covid vaccine. He had no idea it would be their last conversation ever
The issue here is that no young people needed to get the vaccine. It was only the elderly who were at serious risk of dying. And even oldies were often not seriously affected. I am 80 but cruised through it all with two RAT tests showing negative.
So all the vaccination pressure on young people was evil. It just added real risks to them with no benefit
The devastated family of a fit and healthy young actor who died a fortnight after taking a Covid vaccine have called out the callous 'indifference' of society and government to her death.
Katie Lees, 34, took the first dose of the AstraZeneca vaccine in July 2021, driven by her desire to 'do her bit' to help bring lockdown to an end.
But just 13 days later her family were forced to make the harrowing decision to turn off her life support.
Ms Lees, an actor and comedian who lived in Sydney's inner-west, had suffered a severe vaccine-induced blood clot in her brain.
'The last time I ever spoke to her on the morning of July 22 (and) she said, "I’m getting my AstraZeneca this afternoon." She said to me how proud she was for doing it,' Katie's father, Ian, told news.com.au.
'It turned out that was the last time I would ever speak to her. She was actually following the government’s advice, trying to do the right thing for the sake of the community.'
Mr Lees, 66, said the hardest part about his daughter's death was that people didn't believe the vaccine had killed her and met the news with 'silence, mockery, discrediting and disbelief'.
'We’d say to people our daughter died from the AstraZeneca vaccine and they’d say, "Oh really? How do you know?",' he said.
In a public submission to the federal government’s Covid Response Inquiry, Ms Lee's parents said they were galled by the 'indifference of our society to her death'.
'Every morning, our first thought is how Katie died and the sinking feeling that we were used and discarded by our government, by AstraZeneca and by our society,' they wrote.
They added: 'Katie did not need the vaccine — she wouldn’t have died if she got Covid.
'Katie took this action, not because she was worried about getting Covid, but because she was deeply concerned about the impact of lockdowns on the life of communities and the mental health of individuals.'
The AstraZeneca vaccine was estimated to have saved millions of lives during the pandemic but it also caused rare, and sometimes fatal, blood clots.
In April, AstraZeneca admitted in a UK court that its vaccine could, in very rare instances, could lead to Thrombosis with Thrombocytopenia Syndrome, which causes people to have blood clots and a low blood platelet count.
The vaccine, which was discontinued in Australia in March 2023, was withdrawn globally last month with the manufacturer citing commercial reasons for the decision.
Of the 14 Australians acknowledged by the Therapeutic Goods Administration (TGA) to have died from Covid vaccines, 13 were from AstraZeneca and one from Moderna.
Ms Lees developed headaches and a rash immediately after her vaccination but doctors did not think anything of it. Just over a week later on August 1 she woke up with a severe headache and started vomiting. A CT scan showed a severe clot in her brain.
'Katie slipped into deep unconsciousness around 3pm and never regained consciousness,' her parents wrote in their submission to the inquiry.
The devastated family said that they had been left 'emotionally, mentally and physically traumatised by the way Katie died, the lack of support from government and the pharmaceutical industry and the alienation we feel from the mainstream narrative in our society'.
The family who received $70,000 in compensation for Katie’s death, said they hated being branded 'anti-vaxxers'.
https://www.dailymail.co.uk/news/article-13512289/Katie-Lees-AstraZeneca-vaccine-died.html
**************************************************Well-Designed Meta-Analysis Suggests Ivermectin Could be Used for Mild-to-Moderate COVID-19; But Proceed with Caution
Medical research affiliated with Xiamen University, Southeast University and Xiamen University Schools of Medicine designed a systematic, meta-analysis, part of an ongoing investigation into the use of ivermectin as an off-label regimen for the COVID-19 indication. A controversial topic, one which is the West among medical establishments is basically settled against use, nonetheless, the drug’s use continues in many parts of the world including the United States. Hence the interest in ongoing study and in this case, the authors led by Zhilong Song at Xiamen University School of Public Health and colleagues scoured key repositories (PubMed/Medline, EMBASE, the Cochrane Library, Web of Science, medRxiv and bioRxiv) to collect all relevant studies tracking till June 2023.
Their meta-analysis endpoint included A) all-cause mortality; B) mechanical ventilation (MV) requirement, C) PCR negative conversion and D) adverse events (AEs) of course representing the safety of the drug. To assess and mitigate bias risk plus evaluate quality of evidence, the authors utilized the Revman 5.4 software package. A total of 33 randomized controlled trials (RCTs) covering 10,849 patients were included in this study. There was no significant difference in all-cause mortality rates or PCR negative conversion between ivermectin and controls.
However, when evaluating MV requirement the authors report significant differences (RR 0.67, 95% CI 0.47–0.96) as well as adverse events (AEs) (RR 0.87, 95% CI 0.80–0.95) between the two groups. The authors conclude, “Ivermectin could reduce the risk of MV requirement and AEs in patients with COVID-19 without increasing other risks. In the absence of a better alternative, clinicians could use it with caution.”
This is an important point given recent studies revealing the leading antiviral against COVID-19 Paxlovid did not have any impact as compared to the placebo. A study TrialSite published yesterday also showed neither Paxlovid nor molnupiravir had the expected impact against important endpoints such as mortality.
Conducted by the prestigious RECOVERY investigators at the University of Oxford, the findings are not a good look for both Pfizer and Merck. The results have not yet been peer-reviewed.
This topic is not trivial, given the fact that COVID-19 vaccination failed to eradicate the pathogen sufficiently to lead to herd immunity. A dynamic, ever-mutating virus, SARS-CoV-2 will continue circling the globe. Hence the importance of various antiviral options.
Interestingly, the Chinese researcher points to multiple changing variants plus “anti-vaccination movements” worldwide as a factor driving the ongoing ivermectin discussion.
Again, while the U.S. medical establishment has come to a consensus that ivermectin offers no benefit even for mild to moderate COVID-19, sufficient data around the world points to the potential sustainability of an alternative account.
The authors point to some focused websites tracking the effectiveness of IVM for COVID-19 (covid19criticalcare.com) and (https://ivmmeta.com). The Chinese authors argue that these resources are considered misinformation. Why? “Most of which are not peer-reviewed, do not present the eligible criteria used in the selection process, and do not display statistical criteria for assessing the effectiveness and heterogeneity among included studies.”
Regardless, the authors behind this latest study acknowledge the criticality of drug repositioning, a tried-and-true pathway to new potential indications.
Does ivermectin fit the classic candidate as a repositioned drug—with the prerequisite safety and pharmacokinetic profiling? A semisynthetic, anti-parasite agent associated with Nobel Prize-winning scientists, at least in a cell culture in a lab setting, the drug inhibits viral and replication scenarios. In fact, it can reduce the concentration of viral RNA by nearly 5000-fold as was demonstrated in Australia in Spring 2020.
Especially when including long COVID, the demand for effective pharmacotherapies targeting SARS-CoV-2 will likely only grow.
Findings
No significant difference in all-cause mortality rates or PCR negative conversion between IVM and controls. There were significant differences in MV requirement (RR 0.67, 95% CI 0.47–0.96) and AEs (RR 0.87, 95% CI 0.80–0.95) between the two groups. Ivermectin could reduce the risk of MV requirement and AEs in patients with COVID-19, without increasing other risks. In the absence of a better alternative, clinicians could use it with caution.
***********************************************
Dr Nick Coatsworth makes a stunning admission about the Covid jab
Dr Nick Coatsworth, who helped lead Australia's response to Covid-19, has revealed he will not be getting any more vaccinations for the virus.
Speaking with Ben Fordham on 2GB on Wednesday, the former public face of Australia's fight against Covid-19 made the stunning admission he is done with Covid vaccines.
'Are you still being vaccinated for Covid?' Fordham asked.
'No,' Dr Coatsworth said.
'When did you stop doing that?'
'About two years ago, I had three vaccines, and that's been enough for me.'
'Any reason why?' Fordham asked.
'Because I don't think I need any more Ben, and the science tells me that I don't,' Dr Coatsworth said.
The current advice from the Department of Health and Aged care states: 'Regular COVID-19 vaccinations (also known as boosters) are the best way to maintain your protection against severe illness, hospitalisation and death from Covid-19.
'They are especially important for anyone aged 65 years or older and people at higher risk of severe Covid-19.
'As with all vaccinations, people are encouraged to discuss the vaccine options available to them with their health practitioner.'
This is not the first controversial statement Dr Coatsworth - Australia's former deputy chief health officer - has made about the Covid vaccine.
In February this year Dr Coatsworth admitted that imposing vaccine mandates was wrong in the wake of the Queensland Supreme Court finding that forcing police and paramedics to take the jab or lose their jobs was 'unlawful'.
In his inquiry submission Dr Coatsworth said mandates should only be a 'last resort', 'time limited', and be imposed by governments not employers.
Although Dr Coatsworth noted Australia had assembled a top team of medical experts to advise on managing the pandemic, he said they lacked an ethical framework meaning the focus became too narrow.
'This allowed the creation of a 'disease control at all costs' policy path dependence, which, whilst suited to the first wave, was poorly suited to the vaccine era,' he said.
Dr Coatsworth argued the restriction and testing policies adopted to constrain the first deadliest strain of Covid in 2020 lingered well past their relative benefit, leading to nationwide workforce and testing shortages.
He also thought the differing approaches among states, and between states and the federal government, confused the public and eroded human rights.
'I strongly encourage the inquiry to recommend amendment of the Biosecurity Act to ensure that all disease control powers are vested in the federal government during a national biosecurity emergency,' Dr Coatsworth wrote.
Dr Coatsworth was appointed as one of three new deputy chief medical officers under Brendan Murphy at the start of the pandemic in March 2020.
He now works as a doctor in Canberra and is contracted to Nine-Fairfax channels and newspapers as a presenter and health expert.
He appeared on the Fordham program to spruik a new TV show he is presenting with Tracy Grimshaw, Do You Want To Live Forever?
*************************************************
Also see my other blogs. Main ones below:
http://edwatch.blogspot.com (EDUCATION WATCH)
http://antigreen.blogspot.com (GREENIE WATCH)
http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)
http://australian-politics.blogspot.com (AUSTRALIAN POLITICS)
http://snorphty.blogspot.com (TONGUE-TIED)
https://immigwatch.blogspot.com (IMMIGRATION WATCH)
https://awesternheart.blogspot.com (THE PSYCHOLOGIST)
http://jonjayray.com/blogall.html More blogs
*********************************************************
No comments:
Post a Comment